Tangier disease (TD)
Two Long-Term Follow-Up Cases Preventing Atherosclerosis by Hormone Replacement Therapy-CETP Deficiency and Tangier Disease
5
Platelet activating factor levels and metabolism in tangier disease: a case study
10
Properties of the Plasma Very Low and Low Density Lipoproteins in Tangier Disease
14
Isolation and Characterization of an Abnormal High Density Lipoprotein in Tangier Disease
12
Characterization of high density lipoproteins in patients heterozygous for Tangier disease
12
Studies on the Protein Defect in Tangier Disease: ISOLATION AND CHARACTERIZATION OF AN ABNORMAL HIGH DENSITY LIPOPROTEIN
16
The Tangier disease gene product ABC1 controls the cellular apolipoprotein mediated lipid removal pathway
8
Tangier Disease: HIGH DENSITY LIPOPROTEIN DEFICIENCY DUE TO DEFECTIVE METABOLISM OF AN ABNORMAL APOLIPOPROTEIN A I (APOA ITANGIER)
13
The Storage Lipids in Tangier Disease: A PHYSICAL CHEMICAL STUDY
11
The lipoprotein abnormality in Tangier disease: quantitation of A apoproteins
12
In vivo metabolism of proapolipoprotein A I in Tangier disease
7
Defective removal of cellular cholesterol and phospholipids by apolipoprotein A I in Tangier Disease
11
Effects of miglustat treatment in a patient affected by an atypical form of Tangier disease
7
The Inheritance of High Density Lipoprotein Deficiency (Tangier Disease)
10
Efficacy of plants extracts on cercospora leaf spot incidence and severity of groundnut (Arachis hypogaea L ) In vivo
7
Transdermal buprenorphine and fentanyl patches in cancer pain: a network systematic review
10
Measuring the atmospheric organic aerosol volatility distribution: a theoretical analysis
13
EMOTIONAL SPEECH BY TD PSOLA FOR TELUGU
11
Renal safety of lithium in HIV-infected patients established on tenofovir disoproxil fumarate containing antiretroviral therapy: analysis from a randomized placebo-controlled trial
6
First report of L1014F kdr mutation in Culex pipiens complex from Morocco
7